DCP1A and colorectal carcinoma: In order to determine whether TTP loss in CRC is associated with P-bodies alteration, we analyzed the expression of TTP and the P-body marker Dcp1a in normal human colon, adenoma, and adenocarcinoma FFPE tissue arrays (Figure 11A).